Compounds > mk 0663
Page last updated: 2024-09-03

mk 0663 and n-vinyl-2-pyrrolidinone

mk 0663 has been researched along with n-vinyl-2-pyrrolidinone in 7 studies

Compound Research Comparison

Studies
(mk 0663)		Trials
(mk 0663)		Recent Studies (post-2010)
(mk 0663)		Studies
(n-vinyl-2-pyrrolidinone)		Trials
(n-vinyl-2-pyrrolidinone)		Recent Studies (post-2010) (n-vinyl-2-pyrrolidinone)
5491732657,5332282,213

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mahadik, K; Paradkar, A; Shimpi, S; Takada, K1
Karekar, P; Pore, Y; Sancheti, P; Shah, M; Vyas, V1
Mahadik, KR; Paradkar, AR; Shimpi, SL1
Parmar, VK; Patel, HM; Rathod, I; Shah, SA; Suhagia, BN1
Bansal, AK; Bansal, SS; Kaushal, AM1
Bansal, AK; Dani, P; Puri, V1
Jędrzejowska, A; Knapik-Kowalczuk, J; Pacułt, J; Paluch, M; Rams-Baron, M1

Other Studies

7 other study(ies) available for mk 0663 and n-vinyl-2-pyrrolidinone

ArticleYear
Application of polyglycolized glycerides in protection of amorphous form of etoricoxib during compression.
    Chemical & pharmaceutical bulletin, 2007, Volume: 55, Issue:10

    Topics: Cyclooxygenase Inhibitors; Drug Stability; Etoricoxib; Fats; Glycerides; Hydrogen Bonding; Oils; Polyethylene Glycols; Povidone; Pyridines; Sulfones; Tablets; Technology, Pharmaceutical; Time Factors; X-Ray Diffraction

2007
Effect of PVP K30 and/or L-arginine on stability constant of etoricoxib-HPbetaCD inclusion complex: preparation and characterization of etoricoxib-HPbetaCD binary system.
    Drug development and industrial pharmacy, 2009, Volume: 35, Issue:1

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Arginine; beta-Cyclodextrins; Cyclooxygenase Inhibitors; Drug Stability; Etoricoxib; Excipients; Freeze Drying; Magnetic Resonance Spectroscopy; Povidone; Pyridines; Solubility; Spectroscopy, Fourier Transform Infrared; Sulfones; X-Ray Diffraction

2009
Study on mechanism for amorphous drug stabilization using gelucire 50/13.
    Chemical & pharmaceutical bulletin, 2009, Volume: 57, Issue:9

    Topics: Calorimetry, Differential Scanning; Celecoxib; Cyclooxygenase Inhibitors; Drug Compounding; Drug Stability; Etoricoxib; Excipients; Fats; Hydrogen Bonding; Oils; Povidone; Pyrazoles; Pyridines; Spectrophotometry, Infrared; Sulfonamides; Sulfones; X-Ray Diffraction

2009
Preparation and characterization of etoricoxib-polyethylene glycol 4000 plus polyvinylpyrrolidone K30 solid dispersions.
    Acta pharmaceutica (Zagreb, Croatia), 2006, Volume: 56, Issue:3

    Topics: Chemistry, Pharmaceutical; Cyclooxygenase Inhibitors; Drug Carriers; Etoricoxib; Polyethylene Glycols; Povidone; Pyridines; Solubility; Sulfones; Time Factors; Wettability

2006
Enthalpy relaxation studies of two structurally related amorphous drugs and their binary dispersions.
    Drug development and industrial pharmacy, 2010, Volume: 36, Issue:11

    Topics: Calorimetry, Differential Scanning; Cyclooxygenase 2 Inhibitors; Drug Stability; Drug Storage; Etoricoxib; Excipients; Humidity; Hydrogen Bonding; Isoxazoles; Povidone; Pyridines; Sulfonamides; Sulfones; Thermodynamics; Transition Temperature

2010
Solubility advantage from amorphous etoricoxib solid dispersions.
    Drug development and industrial pharmacy, 2014, Volume: 40, Issue:1

    Topics: Cellulose; Chemistry, Pharmaceutical; Crystallization; Drug Carriers; Drug Compounding; Drug Stability; Etoricoxib; Phase Transition; Polymers; Polyvinyl Alcohol; Povidone; Pyridines; Solubility; Sulfones; Thermodynamics; Transition Temperature

2014
Changes in Physical Stability of Supercooled Etoricoxib after Compression.
    Molecular pharmaceutics, 2018, 09-04, Volume: 15, Issue:9

    Topics: Calorimetry, Differential Scanning; Crystallization; Drug Stability; Etoricoxib; Povidone

2018